Literature DB >> 25767627

Unusual Adrenal Gland Metastasis in a Patient with Follicular Carcinoma of the Thyroid Evidenced by (18)F-FDG PET/CT and Confirmed by Biopsy.

Federico Caobelli1, Natale Quartuccio2, Claudio Pizzocaro1, Giordano Savelli1, Ugo Paolo Guerra1.   

Abstract

Entities:  

Year:  2014        PMID： 25767627      PMCID： PMC4354791          DOI： 10.1007/s13139-014-0293-1

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN： 1869-3474


× No keyword cloud information.
  10 in total

1.  F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.

Authors:  Andrei Iagaru; I Ross McDougall
Journal:  Clin Nucl Med       Date:  2007-01       Impact factor: 7.794

2.  Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.

Authors:  Richard J Robbins; Qiang Wan; Ravinder K Grewal; Roland Reibke; Mithat Gonen; H William Strauss; R Michael Tuttle; William Drucker; Steven M Larson
Journal:  J Clin Endocrinol Metab       Date:  2005-11-22       Impact factor: 5.958

3.  An unusual 131I-avid adrenal metastasis from follicular thyroid carcinoma identified by 131I-SPECT/CT.

Authors:  Yan-Li Xue; Hong-Jun Song; Zhong-Ling Qiu; Quan-Yong Luo
Journal:  Clin Nucl Med       Date:  2012-09       Impact factor: 7.794

4.  Molecular diagnosis of a BRAF papillary thyroid carcinoma with multiple chromosome abnormalities and rare adrenal and hypothalamic metastases.

Authors:  John A Copland; Laura A Marlow; Sandra F Williams; Stefan K Grebe; Michelle L Gumz; William J Maples; Victor E Silverman; Robert C Smallridge
Journal:  Thyroid       Date:  2006-12       Impact factor: 6.568

Review 5.  Aggressive variants of follicular cell derived thyroid carcinoma; the so called 'real thyroid carcinomas'.

Authors:  Zubair Baloch; Virginia A LiVolsi; Rashmi Tondon
Journal:  J Clin Pathol       Date:  2013-04-27       Impact factor: 3.411

6.  Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.

Authors:  Gulin Ucmak Vural; Burcu Esen Akkas; Nur Ercakmak; Sandip Basu; Abass Alavi
Journal:  Clin Nucl Med       Date:  2012-10       Impact factor: 7.794

7.  Unusual case of adrenal and renal metastases from papillary carcinoma of thyroid.

Authors:  Gaurav Malhotra; Trupti S Upadhye; Epari Sridhar; Ramesh V Asopa; Parul S Garde; Sachin Gawde; Venkatesh Rangarajan
Journal:  Clin Nucl Med       Date:  2010-09       Impact factor: 7.794

Review 8.  Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers.

Authors:  Jena D French
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

9.  Papillary thyroid cancer with bilateral adrenal metastases.

Authors:  Nadia Batawil
Journal:  Thyroid       Date:  2013-09-10       Impact factor: 6.568

Review 10.  The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery.

Authors:  Kyoungjune Pak; Seong-Jang Kim; In Joo Kim; Bo Hyun Kim; Sang Soo Kim; Yun Kyung Jeon
Journal:  Endocr Relat Cancer       Date:  2013-07-04       Impact factor: 5.678
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.